Cartesian Therapeutics Inc (RNAC)
25.74
+0.14
(+0.55%)
USD |
NASDAQ |
May 06, 16:00
26.52
+0.78
(+3.03%)
Pre-Market: 08:50
Cartesian Therapeutics Shareholders Equity (Quarterly): -440.18M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -440.18M |
| September 30, 2023 | 60.33M |
| June 30, 2023 | 65.45M |
| March 31, 2023 | 74.58M |
| December 31, 2022 | 93.83M |
| September 30, 2022 | 84.91M |
| June 30, 2022 | 89.61M |
| March 31, 2022 | 55.76M |
| December 31, 2021 | 22.52M |
| September 30, 2021 | -18.73M |
| June 30, 2021 | -4.222M |
| March 31, 2021 | -19.57M |
| December 31, 2020 | -18.01M |
| September 30, 2020 | -7.382M |
| June 30, 2020 | -13.05M |
| March 31, 2020 | -8.763M |
| December 31, 2019 | 8.397M |
| Date | Value |
|---|---|
| September 30, 2019 | -4.915M |
| June 30, 2019 | 0.056M |
| March 31, 2019 | 14.82M |
| December 31, 2018 | -5.418M |
| September 30, 2018 | 10.00M |
| June 30, 2018 | 24.26M |
| March 31, 2018 | 41.58M |
| December 31, 2017 | 51.81M |
| September 30, 2017 | 65.08M |
| June 30, 2017 | 78.18M |
| March 31, 2017 | 41.09M |
| December 31, 2016 | 54.96M |
| September 30, 2016 | 65.44M |
| June 30, 2016 | 68.78M |
| March 31, 2016 | 14.34M |
| December 31, 2015 | -116.49M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-440.18M
Minimum
Dec 2023
93.83M
Maximum
Dec 2022
1.085M
Average
0.056M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 16.76M |
| Adial Pharmaceuticals Inc | 4.084M |
| Poseida Therapeutics Inc | 103.70M |
| Viracta Therapeutics Inc | 18.32M |
| Biomea Fusion Inc | 135.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 305.05M |
| Total Liabilities (Quarterly) | 745.23M |
| Current Ratio | 1.330 |
| Net Debt Paydown Yield | 4.68% |